From Name:
From Email:
To Name:
To Email:

Optional Message:


Cures-for-dollars model comes undone as biotech stocks sink

from Bloomberg

For the last five years, biotechnology and pharmaceutical stocks have surged on an assumption about the companies that invent and sell drugs for American patients: Invent amazing treatments that save lives and cure the sick, and you can charge pretty much what you want. That thesis is under more pressure than any time in recent history, in part because of increasing scrutiny of how some drugmakers price their medicine. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063